Anest. intenziv. Med. 2006;17(3):164-170
Analysis of the specificity and sensitivity of procalcitonin in relation to other markers of inflammation in critically ill patientsIntensive Care Medicine - Original Paper
- 1 Klinika anesteziologie a resuscitace VFN a 1. LF UK Praha
- 2 Katedra klinické biochemie IPVZ Praha
- 3 Oddělení klinické biochemie Nemocnice Kladno
- 4 Ústav klinické biochemie a laboratorní diagnostiky VFN a 1. LF UK Praha
Objective:
To evaluate the diagnostic specificity and sensitivity of procalcitonin (PCT) in comparison with C-reactive protein (CRP) and other inflammatory markers in relation to clinical status and microbiology examinations.
Design:
Prospective study in ICU patients.
Setting:
Department of Anaesthesiology and Intensive Care, University Hospital, 1st Medical Faculty, Charles University, Prague.
Materials and Methods:
164 examinations of PCT, CRP, orosomucoid, prealbumin, fibrinogen, INR, white cell and platelet count were evaluated in 43 patients. APACHE II was calculated on admission, SOFA daily. SIRS, MODS, microbiology findings, blood culture and signs of infection were also assessed. Statistical methods included chi-square, Wilcoxon unpaired test, nonparametric Kruskal-Wallis test, ROC analysis and comparison of area under the curve (AUC).
Results:
AUC higher than 0.6 was recorded in the following variables: MODS: temperature 0.700, PCT 0.683, platelets 0.657. SIRS: temperature 0.852, white cell count (WCC) 0.761, PCT 0.694, fibrinogen 0.612. SOFA: PCT 0.756, platelets 0.711, temperature 0.654, WCC 0.646. Blood culture: albumin 0.703, fibrinogen 0.686, orosomucoid 0.666, temperature 0.649. APACHE: platelets 0.685, PCT 0.605, WCC 0.602. Bacteriology: temperature 0.653, PCT 0.627. Apparent infection: temperature 0.694, fibrinogen 0.680. There was significant difference between survivors and non-survivors in PCT (P = 0.00), platelets (P = 0.00), WCC (P < 0.03) and temperature (P < 0.05).
Conclusion:
PCT was a more effective marker of sepsis-related complications in ICU patients than CRP or other markers of inflammation. ROC analysis was a suitable tool for confirmation of these relations.
Keywords: procalcitonin; C-reactive protein; acute phase reactants; ROC analysis; SOFA; SIRS; MODS
Published: June 1, 2006 Show citation
ACS | AIP | APA | ASA | Harvard | Chicago | Chicago Notes | IEEE | ISO690 | MLA | NLM | Turabian | Vancouver |
References
- Maruna, P. Prokalcitonin. Praha : Triton 2003, 140 s. ISBN 80-7254-410-1.
- Kazda, A. et al. Prokalcitonin u kriticky nemocných. Klin. Biochem. Metab., 2005, roč. 13(34), č. 1, s. 4-9.
- Simon, L. et al. Serum procalcitonin and C-reactive protein as markers of bacterial infection: a systemic review and meta-analysis. Clin. Infectious Dis., 2004, 39, p. 206-217.
Go to original source...
Go to PubMed...
- Giamarellou, H. et al. Potential use of procalcitonin as a diagnostic criterion in febrile neutropenia: experience from a multicentre study. Clin. Microbiol. Infect, 2004, 10, p. 628-633.
Go to original source...
Go to PubMed...
- Kazda, A. et al. Prokalcitonin u akutních pankreatitid a v septických stavech. Klin. Biochem. Metab., 2002, roč. 10 (31), č. 1, s. 32-37.
- Chirouze, C. et al. Low serum procalcitonin level accurately predicts the absence of bacteremia in adult patients with acute fever. Clinical Infection Dis., 2002, 35, p. 156-161.
Go to original source...
Go to PubMed...
- Hájek, T. et al. Role prokalcitoninu ve sledování nemocných po kardiochirurgických výkonech. Rozhledy v chirurgii, 2004, 83, č. 7, s. 337-341.
- Šimák, J. et al. Patofyziologie systémové zánětlivé odpovědi. Anest. neodklad. Péče, 1995, roč. 6, č. 5, s. 165-168.
- Bone, R. C. et al. Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. Chest, 1992, 101, p. 1644-1655.
Go to original source...
Go to PubMed...
- Bone R. C. et al. The ACCP-SCCM consensus conference on sepsis and organ failure. Chest, 1992, 101, p. 1481-1483.
Go to original source...
Go to PubMed...
- Erten, N. et al. The predictive and diagnostic values of procalcitonin and C-reactive protein for clinical outcome in febrile neutropenic patients. J. Chin. Med. Assoc., 2004, 67, p. 217-221.
Go to PubMed...
- Giamarellos-Bourboulis, E. J. et al.:Assessment of procalcitonin as a diagnostic marker of underlying infection in patients with febrile neutropenia. Clinical Infection Dis., 2001, 32, p. 1718-1725.
Go to original source...
Go to PubMed...